CLINICAL_TRIALS
trial_result
· 2021-07-15
Clinical Trial Update: Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block [Phase 3]
Summary
A Phase 3 trial comparing chloroprocaine 2% to ropivacaine 0.75% for ultrasound-guided axillary nerve block completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sintetica SA | Conditions: Axillary Nerve Block | Phase 3 | Status: COMPLETED | Results posted: 2021-07-15